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Abstract
Background: The aim of this study was to evaluate the contribution of bronchial epithelium to
airway inflammation, with focus on mRNA and protein expression of cytokines of innate immunity
IL-6, IL-10 and TNF-α, in horses with Recurrent Airway Obstruction (RAO) during exacerbation
and in remission.
Results: Despite marked clinical and physiologic alterations between exacerbation and after
remission in the RAO horses no differences were detected in either cytokine mRNA or protein
levels. Moreover, the expression of investigated cytokines in RAO horses on pasture did not differ
from controls.
In comparing real-time PCR analysis to results of immunohistochemistry only IL-10 mRNA and
protein levels in RAO horses on pasture were significantly correlated (rs = 0.893, p = 0.007).
Curiously, in controls examined on pasture the TNF-α protein level was positively correlated to
IL-10 mRNA expression (rs = 0.967, p = 0.007) and negatively correlated to IL-6 mRNA expression
(rs = -0.971, p = 0.001).
Conclusion: Given the complementary relationship of assessing cytokines directly by
immunohistochemistry, or indirectly by PCR to mRNA, the lack of significant changes in either
mRNA or protein levels of IL-6, IL-10 or TNF-α mRNA in RAO horses in exacerbation suggests
that these particular cytokines in bronchial tissue may not play a substantive role in the active
inflammation of this disease. To support this contention further studies examining time dependency
of expression of IL-6, IL-10 or TNF-α are needed, as is expansion of the range of cytokines to
include other key regulators of airway inflammation.
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Background
Bronchial epithelium acts not only as physical barrier but
also is a key factor of remodelling and secretion of inflammation mediators in airways [1-4]. In addition to sampling methods such as bronchoalveolar lavage (BAL) and
induced sputum, endobronchial biopsies have been used
as a key research tool over the last decade to study the
importance of bronchial epithelium in inflammatory diseases and define disease progression in asthma and COPD
in humans [1,5-7], and evaluate the effects of different
drug treatments and environmental effects on bronchial
epithelium [8,9]. Besides identifying morphological
changes, examination of bronchial tissue can provide
information on mRNA expression and subsequent levels
of translated inflammatory mediators directly within the
tissue, both by resident cells and infiltrating inflammatory
cells using immunohistochemistry (IHC) [10-12].
Horses are commonly affected by the disease "Recurrent
Airway Obstruction (RAO)", which has many similarities
with asthma in people. Inflammatory changes in the airways of horses with RAO have been studied predominately on the basis of cell samples collected by BAL, or less
commonly, by analysis of other respiratory tract samples,
such as bronchial brushing, tracheal lavage, exhaled
breath condensate, and even lung tissue samples [13-19].
Most of our current understanding about the mechanism
of inflammation and involvement of various regulatory or
effector cytokines in the airways of horses with RAO has
been derived from samples obtained by BAL. Apart from
recent work of Ainsworth et al [14], similar assessment of
bronchial tissues or direct identification of tissue cytokine
levels by immunohistochemistry, which has been invaluable in human respiratory research, remains poorly investigated in horses.
The aim of this study was to evaluate the contribution of
bronchial epithelium to airway inflammation in horses
with RAO during exacerbation and in remission, with initial focus on relative cytokine mRNA and protein expression of cytokines IL-6, IL-10 and TNF-α, that are involved
in innate non-specific immunity. The differences in
mRNA levels measured by quantitative real-time PCR
were compared with the corresponding protein levels in
epithelial tissue measured by IHC. The epithelial cytokine
levels in RAO horses during remission were also compared against samples from healthy controls on pasture.

Results
Clinical examination and pulmonary function test
There was no statistical difference in age and body weight
in principal and control animals. The clinical score of
RAO horses on pasture was statistically lower than during
exacerbation (median ± SD, 7.00 ± 0.90 versus 3.00 ±
0.69, p = 0.02), but did not differ from control horses on
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pasture (3.00 ± 0.69 RAO versus 2.00 ± 0.00 pasture controls, p = 0.10). The RAO horses showed a significant
worsening of pulmonary function during exacerbation as
a response to provocation with mouldy hay, characterised
by significant increase in ΔPplmax (41.80 ± 17.27 cmH20
versus 9.70 ± 1.67 cmH20, p = 0.02) and RL (2.96 ± 0.76
cmH20/L/s versus 0.08 ± 0.02 cmH20/L/s, p = 0.02). During respiratory exacerbation in RAO horses, there was also
a significant decrease in Cdyn after removing one outlier
(0.21 ± 0.33 L/cmH20, versus 1.53 ± 0.51 L/cmH20 p =
0.036). During pasture the lung function improved in
RAO horses, but remained significantly different when
compared to healthy controls which had ΔPplmax of 5.89
± 1.87 cmH20, RL of 0.44 ± 0.12 cm H20/L/s and Cdyn of
1.54 ± 0.47 L/cmH20.
BAL cytology
The total cell count, percentage of neutrophils and total
number of neutrophils in BAL was statistically higher (p =
0.02) in RAO horses post provocation compared to samples taken during remission on pasture (neutrophil percentage, 48.00 ± 13.31 versus 11.00 ± 10.66). During the
pasture remission there was no statistical difference in
BAL neutrophil percentage in RAO horses compared to
controls (11.00 ± 10.66 versus 9.60 ± 6.82). Neither the
percentage of neutrophils nor absolute number of neutrophils correlated with levels of investigated cytokine
mRNA or protein expression. For the remaining cell types
the percentage of macrophages showed a negative correlation with TNF-α mRNA expression in RAO horses during
pasture (rs = -0.893, p = 0.007) but the biological relevance of this was of questionable significance.
Immunohistochemistry of endobronchial biopsies
While there was a tendency for bronchial epithelial levels
of IL-6 and TNF-α in RAO horses to increase during crisis
the differences did not reach statistical significance (Table
1, Figure 1). Expression of investigated cytokines in RAO
horses and controls on pasture did not differ, nor was any
correlation found between IHC expression of different
cytokines within individual horses.
Real-time PCR
The differences in cytokine mRNA levels from samples
during crisis and on pasture are shown in Figure 2. In
comparing RAO horses in crisis versus remission the only
significant alteration in endobronchial tissue cytokine
regulation was a 1.1 (median) fold decrease in TNF-α
mRNA when in crisis (p = 0.035). The mRNA levels of
investigated cytokines did not correlate with each other.
Differences in expression of investigated cytokine mRNA
in RAO horses and controls on pasture were not detected.
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between investigated cytokines when comparing real-time
PCR analysis to results of immunohistochemistry.

Discussion
The horses in our study showed changes in pulmonary
function and clinical scores that confirmed a period of respiratory crisis with neutrophilic inflammation and airway
obstruction and also a period of remission. Surprisingly,
we were unable to detect significant differences in either
mRNA or protein expression in investigated cytokines in
endobronchial tissue between provocation and remission. The only statistically significant finding was a small
(1.1-fold down-regulation of TNF-α mRNA in endobronchial biopsies in RAO horses after provocation). However,
given the extreme sensitivity of real time-PCR methodology this difference was unlikely of clinical relevance.

Figure
IL-10
horse
expression
in1exacerbation
in the bronchial epithelium of an RAO
IL-10 expression in the bronchial epithelium of an RAO
horse in exacerbation.
Immunohistochemistry versus real-time PCR
IL-10 mRNA levels in RAO horses on pasture was significantly correlated with cytokine expression measured by
IHC (rs = 0.893, p = 0.007) whereas IL-6 and TNF-α
mRNA showed no correlation to their corresponding
cytokines on IHC. Curiously, in controls examined on
pasture, the TNF-α expression measured by IHC was positively correlated to IL-10 mRNA levels (rs = 0.967, p =
0.007) and negatively correlated to IL-6 mRNA levels (rs =
-0.971, p = 0.001). In controls there was no correlation

Earlier studies report conflicting results regarding IL-6 and
IL-10 bioactivity or mRNA levels in BAL cells from RAO
horses after challenge. However, these results may be due
to differences in sampling time or the type of inhalation
provocation [20,21]. Regarding IL-10, others have shown
that inhalation challenge with lipopolysaccharide (LPS)
elevates IL-10 mRNA expression in both BAL alveolar
macrophages [20] and peripheral blood cells in RAO-susceptible horses [22]. However inhalation challenge with
other agents failed to induce this up-regulation in BAL
macrophages [20]. Thus it is possible that not only the
sampling time, but also the mode and individual components of challenge agent may influence the dynamics of
cytokine regulation. In our study, the negative correlation
of bronchial TNF-α levels to IL-6 mRNA levels in controls
examined on pasture may indicate the time-dependent
changes in the expression of these two cytokines [23] or
simply be coincidental. The positive correlation of IL-10
mRNA expression with TNF-α measured by IHC (rs =
0.967, p = 0.007) may have reflected the immunoregulatory properties of IL-10 as a counterbalance to TNF-α [24].
There are also several other possible reasons that this
study did not detect alteration of these cytokines under
exacerbation. Firstly, the time point for sample collection
in correlation to provocation might have failed to capture
a temporally related enhancement in examined cytokine
expression. Others workers have shown time-dependent

Table 1: Bronchial epithelium expression of IL-6, IL-10 and TNF-α in RAO horses on crisis and in remission, and in control horses on
pasture.

Cytokine

RAO provocation

RAO pasture

Controls pasture

RAO, p-value provocation/pasture

IL-6
IL-10
TNF-α

1.08 (0.83–1.64)
3.68 (2.46–6.11)
4.18 (1.26–5.03)

0.63 (0.28–1.97)
4.18 (2.28–5.38)
1.21 (0.95–2.51)

0.94 (0.57–1.18)
2.64 (1.77–5.95)
1.18 (0.54–2.10)

p = 0.67, NS
p = 0.21, NS
p = 0.45, NS

Immunohistochemical determination of percentage (%) of positively stained area of bronchial epithelium for selected cytokines. Values are given as
medians (1st–3rd quartiles). NS = Not significant.
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[11]. When planning the study, the choice of equine antibodies was limited. At present there are several equine
specific antibodies available for the
investigated
cytokines.
The primers used in PCR have been evaluated and validated in other studies. Moreover, companion studies in
these RAO subjects have shown increased expression during crisis of other inflammatory mediators in BAL and epithelial cells collected by bronchial brushings and in
biopsies [27-29], indicating ongoing inflammatory process. Thus, our findings suggest that, within the complex
interrelation of regulatory cytokines, IL-6, IL-10 and TNFα may not play a key role in the inflammation in bronchial tissues in horses with RAO.
Figure 2
Comparative
(fold) cytokine mRNA expression
Comparative (fold) cytokine mRNA expression. The
relative (fold) increase of cytokine mRNA levels (IL-6, IL-10
and TNF-α) is shown with interquartile range and line for
median value. The horizontal line represents theoretical
median value 1 (theoretically no difference between provocation and remission or ΔΔCT = 0, 2 ΔΔC T = 20 = 1).

Apart from IL-10 for the RAO horses at pasture, the lack of
correlation of the cytokine mRNA to protein levels of IL6, IL-10 and TNF-α was not unexpected as regulation of
actual protein level is likely more complex than a direct
relationship to amount of mRNA and the rate of translation and thus the amount of mRNA does not necessarily
directly correlate with the level of protein expressed [30].

Conclusion
expression of inflammatory mediators in horse airways
that occur within hours or days after provocation [1316,18,20]. In contrast, our samples were collected only
once RAO-horses had developed clinical signs of impaired
pulmonary function, (ΔPplmax more than 1.5 kPa), rather
than at a predetermined time after provocation. Alternatively, it can be questioned whether the bronchial epithelial tissues obtained were representative for the study. As
shown in earlier studies in human COPD and asthma
patients, there is variability of distribution of inflammatory cells in bronchial tissue which can require examination of biopsies from more than one airway generation to
increase the statistical power to detect differences between
individuals [25,26]. Of the six biopsies we obtained from
each horse, the first two were from the first generation
bronchus and examined by PCR. The remaining four
biopsies were obtained progressively more distally in the
lung and from these morphologically representative biopsies were then selected for further analysis by IHC. As well,
the small biopsy size, the sampling of the epithelial layer
without underlying deeper mucosa, and the fact that biopsies are generally sampled from more proximal airways
and from subcarinae, are additional limitations to the
sampling procedure. To secure antigen preservation and
optimal morphology for IHC studies, we chose plastic
resin embedding, GMA, used in several human studies
together with acetone fixation containing protease inhibitors. This embedding technique ensures both excellent
antigen preservation for IHC and morphologic overview

These results show that combining quantitative real-time
PCR and IHC methods on bronchial biopsy tissues can
provide a new complementary research tool to study the
role of mediators and structural elements in bronchial tissue associated with the inflammatory process in RAOhorses. Future work should focus on examining temporal
events in the early stages following challenge exposure,
and expanding the range of cytokines examined to study
the role of airway epithelial cells in the immunopathogenesis of RAO.

Methods
Horses
Seven RAO horses with a history of recurrent episodes of
respiratory distress when exposed to dusty stable environment (Mean weight 431 ± SD 90 kg, age 19.7 ± 6.6 years)
and 6 healthy controls (Mean weight 475 ± SD 33 kg, age
16.8 ± 7.9 years) were included in the study. The RAO
horses were sampled once clinical signs appeared following provocation with mouldy hay and straw bedding and
secondly when in remission after two months on pasture,
during which time six healthy horses were also similarly
examined. RAO horses were sampled after provocation as
previously described [31] when pulmonary function
measurements indicated maximum change in transpulmonary pressure (ΔPplmax) above 1.5 kPa [32]. The clinical signs in horses were scored by a blinded observer
according to an earlier reported system [32]. This study
was approved by the institutional animal care and use
committee, University of Liège, Belgium.
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Pulmonary function tests
Pleural pressure changes were measured with oesophageal
balloon catheter connected to a calibrated pressure transducer and the air flow and volume measured through a
facemask by a Fleish pneumotachograph (Model NR4;
Gould Electronics, Eichstetten, Germany). The maximum
transpulmonary pressure, pulmonary resistance and
dynamic compliance were obtained from a lung function
computer (Haemodynamics Respiratory System; ACEC,
Namur, Belgium). Each measurement period averaged 2
min, and average values of 10 representative breaths were
analysed.
Bronchoalveolar lavage
After sedation with romifidine (0.01 mg/kg, iv, Sedivet;
Boehringer Ingelheim, Ingelheim, Germany) and butorphanol tartrate (0.02 mg/kg IV, Torbugesic; Fort Dodge,
Wyeth, Madison, New Jersey, USA) all horses had endoscopically (Pentax, Breda, The Netherlands, 170 cm × 12.9
mm) guided bronchial biopsy followed by BAL.

The BAL was performed with 6 × 60 ml sterile isotonic
saline solution (37°C). Fluid recovered was placed on ice,
samples pooled and aliquots collected for cytologic study.
One aliquot was used to determine total leukocyte counts
manually (THOMA cell; VWR International, Fontenaysous-Bois, France). Another aliquot was centrifuged at 200
× g for 15 minutes (Shandon Cytospin Centrifuge,
Thermo Electron Corporation, Pittsburgh, Pennsylvania,
USA) and stained with May-Grünwald staining. Differential cell counts were determined by counting 200 cells per
slide.
Endobronchial biopsies
Sampling
Six biopsies (approximately 1–2 mm in diameter) were
collected via endoscopy from the bronchial epithelium
from subsegmental (3rd to 4th generation bronchi) and
segmental subcarinae (1st to 2nd generation bronchi) airways with biopsy forceps (reusable, 240 cm, Pentax,
KW3433S, Pentax Corporation, Tokyo, Japan). The first
two biopsies from each horse were taken at the first generation bronchus and immediately frozen in liquid nitrogen
and stored at -70°C until analysis for cytokine mRNA. The
remaining biopsies were immediately placed in chilled
acetone containing protease inhibitors for further preparation until immunostaining.
Biopsy Immunostaining
Biopsies were fixed in chilled acetone containing protease
inhibitors (20 mM iodoacetamide and 2 mM phenyl
methyl sulfonyl fluoride) at -20°C overnight. After fixation, biopsies were processed into glycolmethacrylate
(GMA) resin [31] and stored at -20°C until cutting and
immunostaining. Biopsies from all horses were processed
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with appropriate polyclonal antibodies (Table 1) in the
same batch of immunostaining. Two sections from one
biopsy with optimal morphologic structure from each
horse were cut at 2 μm thickness and placed on poly-LLysine treated slides. Endogenous peroxidises were inhibited using 0.1% sodium azide and 0.3% hydrogen peroxide for 30 minutes. After 3 × 5 minute washes in TRISbuffered saline with 0.1% Triton-X-100 (TBST), non-specific antibody binding was blocked with undiluted culture
medium, Dulbecco's Modified Eagle's Medium (Sigma,
Missouri, US) containing 10% fetal calf serum and 1%
bovine serum albumin (BSA) for 30 minutes. Further
blocking of non-specific antibody binding was then done
by incubation with swine normal serum for 30 minutes.
The primary antibodies IL-6, IL-10 and TNF-α; (Table 2)
diluted in 0.05% TBST with 1% BSA, were applied and
incubated overnight. After rinsing with TBST for 3x5 minutes, biotinylated swine anti goat IgG F(ab´)2 (Dako Glostrup Denmark) was applied for 2 hours, followed by the
streptavidin-biotin horseradish peroxidase complex
(Dako) for another 2 hours. The sections were then visualized with diaminobenzidine (DAB) to yield a brown
colour and counter-stained with Mayer Haematoxylin.
TBST treated biopsies were used as negative controls.
Quantification of epithelial expression of cytokines
Cytokine immunoreactivity was quantified using a colour
video camera (Sony DXC-950P – Sony, Tokyo, Japan)
containing 380,000 effective picture elements (pixels).
The camera was connected to a Leica Imaging Workstation, with specific PC software (Leica Q500IW, Leica
Cambridge UK). The image setting included a possibility
to carefully adjust the individual colour components
being displayed by the system in order to ensure a close
match between the direct image and that being displayed.
Detection of an appropriate colour was quantified using
binary definition of colour images as displayed on the
screen. The binary image required the user to define which
pixel in the image that was to be considered for measurement. In short, the positively stained area was managed as
a grid of pixels containing the binary value 1 (the pixel is
"set") and remaining area contains the binary value 0 (the
pixel is not "set"). All intact epithelium from both sections was used for quantification of epithelial area, from
which positive immunoreactivity area was compared to
the total measured area.
Table 2: Polyclonal antibodies used in IHC staining of bronchial
epithelium.

Anti-equine

Dilution

Source

IL-6
IL-10
TNF-α

1: 40
1: 25
1: 40

R & D SYSTEM, Abingdon, UK
R & D SYSTEM, Abingdon, UK
R & D SYSTEM, Abingdon, UK
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Table 3: Primer sequences and probes for real-time PCR assays.
Gene

Forward primer 5' to 3'

Reverse primer 5' to 3'

Probe 5' to 3'

GAPDHa
IL-6
IL-10
TNF-α

AAG TGG ATA TTG TCG CCA TCA AT
AGC AAG TGT GAA AAC AGC AAG
TTC AGC AGG GTG AAG ACT TTC
GCT CCA GAC GGT GCT TGT G

AAC TTG CCA TGG GTG GAA TC
CAT CAG GCA GGT CTC CTG AT
CTT GGC AAC CCA GGT AAC CCT TA
GCC GAT CAC CCC AA AG TG

TGA CCT CAA CTA CAT GGT CTA CAT GTT TCA
CTG GCA GAA AAC AAC CTG AAT CTT CCA
TGT TGA ACG GGT CCC TGC TGG AG
TGT CGC AGG AGC CAC CAC GCT

Primers and Probes designed from nucleotide sequence for this study. aD.M. Ainsworth et al. Recurrent airway obstruction (RAO) in horses in
characterised by IFN-γ and IL-8 production in bronchoalveolar lavage cells. In: Veterinary Immunology and Immunopathology 96 (2003) 83–91.

Quantitative real-time PCR
The biopsies for PCR were stored at -80°C until analysis.
Isolation of total RNA from biopsies was performed with
Trizol™ (Sigma-Aldrich Corp. AB, Stockholm, Sweden)
according to the manufacturer's instructions. cDNA was
synthesized from 500 ng total RNA using gene specific
primers and Superscript III reverse transcriptase (Invitrogen)

Relative quantification of equine cytokine mRNA expression was performed by quantitative real-time PCR (RTPCR) using a 7300 Real Time System (Applied Biosystem). Primer and probe sequences are listed in table 3.
The RT-PCR reaction was run with Platinum Taq polymerase for 45 cycles of: 95°C, 15 s and 60°C, 1 min. All samples were run in triplicate and non template controls were
included in each run. The RNA levels of the target genes
were normalized against GAPDH RNA levels and the comparative CT ( 2 −ΔΔC T ) method was used for calculating relative cytokine mRNA expression. The PCR efficiencies, as
determined by assaying serial dilutions of RNA, were
approximately equal for the target genes and the housekeeping genes.
Statistical analyses
Statistical comparisons were performed using a commercially available statistical software program (MINITAB).
Because of the low number of animals data were treated
nonparametrically. Descriptive statistics from each sampling period were calculated. The Wilcoxon signed rank
test used to assess for differences between provocation
and remission in RAO-horses, using a two tailed test
(immunohistochemistry, BAL cytology, clinical score,
pulmonary function), and descriptive data for the latter
three categories presented as medians ± SD. The Wilcoxon
signed rank test was also used for relative cytokine expression with PCR analysis where the theoretic median value
1 was used (theoretically no difference between provoca-

tion and remission or ΔΔCT = 0, 2 ΔΔC T = 20 = 1), where
values over 1 indicate up regulation during provocation
compared to pasture. The difference between mean ΔCT

values for RAO-susceptible horses in remission and controls on pasture for each cytokine was used to count differences in cytokine mRNA expression and statistically tested
using the Mann Whitney test. Spearman rank order correlation was used to evaluate the correlation in cytokine
expression with PCR and IHC in biopsies and for correlation between cytokine expression and cytological findings. The results from BAL cell counts and pulmonary
function from controls and principal animals during pasture were analysed using the Mann-Whitney test. A pvalue < 0.05 was set as the level of significance.
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